Delivery Order SPE2DB22D9353-SPE2DB24FX1VU

Award Date 3/25/24
Potential Completion Date 3/26/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,564,171 units of Metformin HCL ER 500 mg tablets over a period ending on March 26, 2024, at a ceiling value of $1,996.80. The contract is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract with DLA,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $3,173.76 and provides for the delivery of Metformin HCl ER 500 mg tablets. The contract is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which has a total potential value of...
The Defense Logistics Agency awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc. valued at six hundred sixty-eight dollars to supply one thousand metformin hydrochloride extended release 500 milligram tablets by June 23, 2023. The order was issued under an existing prime vendor contract vehicle to fulfill pharmaceutical needs for military treatment facilities in the Park Ridge, Illinois area. No set-aside provisions were applied to this delivery order for the generic...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at fifty-five thousand seven hundred dollars to DMS Pharmaceutical Group Inc. to supply one thousand units of metformin hydrochloride extended release five hundred milligram tablets. The place of performance for this contract is located in Park Ridge, Illinois. The period of performance is brief, spanning from June 23, 2023 through June 26, 2023. No subcontractors or set aside designations were...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $3,173.76, is a firm fixed-price delivery order for 4,564,182,979 units of Metformin HCL ER 500 mg Tablets. The award is made under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) SPE2DB valued at up to $4,999,999 through 2025, which enables the DLA to issue delivery orders for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, to provide Metformin HCL 500 mg tablets. The contract has a potential value of $8,796.48 and a completion date of January 29, 2024. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the end of 2025. This single-award...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $44,753.28 by the Defense Logistics Agency Troop Support Medical to provide 8503700521 metformin hydrochloride tablets. This order was issued against the company's indefinite delivery contract with the Defense Logistics Agency, which has a potential value of up to $5 million through December 2025 to supply various pharmaceutical items and medical supplies. As a woman-owned small business, DMS...
The Defense Logistics Agency, a component of the Department of Defense, awarded a firm fixed price delivery order valued at thirty-four thousand one hundred eleven dollars to DMS Pharmaceutical Group Incorporated. The order is for five hundred tablets of metformin hydrochloride extended release 750 milligrams to be delivered from Park Ridge, Illinois by June 22, 2023 in support of the agency's medical supply needs. No subcontractors or set aside designations were indicated. The award utilizes an...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of METFORMIN HCL 1,000 MG TABLET 1000S to the Defense Logistics Agency (DLA). The contract, valued at $1,050.83, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued up to $499,999,999, which allows the DLA to issue delivery...
<p>The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a $334 firm fixed price delivery order for 1,000 metformin HCl ER 500 mg tablets. The order is for delivery of the specified generic pharmaceutical product to a location in Park Ridge, Illinois, with completion required by June 22, 2023. No set-aside provisions or subcontracting arrangements were associated with this small purchase award made under an unspecified DLA pharmaceuticals contract vehicle.</p>
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB24FX1VU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $2,100.00 fixed-price contract is for the delivery of 4,564,244,575 Metformin Hydrochloride Extended-Release 500 milligram tablets. The order was placed against DMS Pharmaceutical Group's existing Indefinite Delivery Vehicle (IDV) contract SPE2DB24FX1VU with DLA, valued at up to $4,999,999 through 2025. This IDV enables DLA to issue delivery orders for a broad range of pharmaceutical and medical products to support military health facilities globally. The contract has no set-aside designation.

Generated 6/24/24, 9:36 AM